Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5980514 | 0.86 | IDO1 (0.35) | IDO1DAOTAAR1CYP17A1CYP21A2 | |
| SCHEMBL16105495 | 0.80 | IDO1 (0.50) | IDO1DAOTAAR1CYP17A1CYP21A2 | |
| SCHEMBL6495103 | 0.78 | TAAR1 (0.63) | IDO1DAOTAAR1GLSMPO | |
| SCHEMBL6926139 | 0.74 | TAAR1 (0.54) | IDO1CYP1A2CYP2D6CYP2C19TAAR1 | |
| SCHEMBL28419954 | 0.73 | CYP1A2 (0.39) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL31650900 | 0.72 | IDO1 (0.44) | IDO1DAOTAAR1CYP17A1CYP21A2 | |
| SCHEMBL3297906 | 0.72 | IDO1 (0.44) | IDO1DAOCA12CA1CA9 | |
| SCHEMBL5978821 | 0.72 | IDO1 (0.32) | IDO1DAOTAAR1 | |
| SCHEMBL28041238 | 0.72 | MAOA (0.46) | TAAR1CYP17A1CYP21A2CYP11B1 | |
| SCHEMBL6489450 | 0.70 | ALDH1A1 (0.43) | IDO1DAOTAAR1CYP17A1CYP21A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6518264-B2 | For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders | AVENTIS PHARMA S.A. (FR) | 2003-02-11 | — | — | US | disclosed |